Carnitine palmitoyltransferase 1a (CPT1a) deficit is linked to advanced CKD [47], whereas the reduced CPT1a expression is attenuated by L-carnitine supplementation [46]; thus, restoration of carnitine-related FAO enzymes might become a potential therapeutic strategy to halt kidney injury (Figure 2). This evidence concerns the gene CPT1A and chronic kidney disease.